Tg(CAG-cre/Esr1*)67Csk
Transgene Detail
|
|
| Symbol: |
Tg(CAG-cre/Esr1*)67Csk |
| Name: |
transgene insertion 67, Chugai Pharmaceutical Co, Ltd |
| MGI ID: |
MGI:5291515 |
| Synonyms: |
Tg(CAG-MerCreMer)67Csk |
| Transgene: |
Tg(CAG-cre/Esr1*)67Csk Location: unknown
|
| Alliance: |
Tg(CAG-cre/Esr1*)67Csk page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(CAG-cre/Esr1*)67Csk expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| chicken |
CAG |
|
|
| |
|
Mutation details: A transgene construct composed a sequence encoding a fusion of two copies of a mutated murine estrogen receptor and cre recombinase (cre/Esr1*) was microinjected into pronuclei of C57BL/6J oocytes. Line 67 was established.
(J:173500)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
CAG
(chicken)
|
| |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:173500 Tominaga T, et al., Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. J Biol Chem. 2011 Jun 3;286(22):20109-16 |
| All: |
2 reference(s) |
|
Analysis Tools
